Survival Prediction for Pancreatic Cancer Patients Receiving Gemcitabine Treatment

Although gemcitabine monotherapy is the standard treatment for advanced pancreatic cancer, patient outcome varies significantly, and a considerable number do not benefit adequately. We therefore searched for new biomarkers predictive of overall patient survival. Using LC-MS, we compared the base-lin...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Matsubara, Junichi, Ono, Masaya, Honda, Kazufumi, Negishi, Ayako, Ueno, Hideki, Okusaka, Takuji, Furuse, Junji, Furuta, Koh, Sugiyama, Emiko, Saito, Yoshiro, Kaniwa, Nahoko, Sawada, Junichi, Shoji, Ayako, Sakuma, Tomohiro, Chiba, Tsutomu, Saijo, Nagahiro, Hirohashi, Setsuo, Yamada, Tesshi
Format: Artigo
Idioma:Inglês
Publicat: The American Society for Biochemistry and Molecular Biology 2010
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2860233/
https://ncbi.nlm.nih.gov/pubmed/20061307
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/mcp.M900234-MCP200
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars